Press Release

Hepatitis C Drug Market Growth, Share, Trends, Industry Analysis, Forecast till 2026

Hepatitis C Drug Market by top key Players are AbbVie Inc., Gilead Sciences, Inc., Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp.,

 

Hepatitis-C Drugs MarketThe global Hepatitis C Drug market will derive growth impetus from the high prevalence of hepatitis C across the world. According to a report published by Fortune Business Insights, titled “Hepatitis C Drug: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 7,866.6 Mn in 2018. Fortune Business Insights states that the market is projected to reach US$ 7,351.7 Mn by 2026, exhibiting a CAGR of -0.9% in the forecast period.

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hepatitis-c-drug-market-101562

Top players in the global Type 1 Hepatitis C Drug Market include:

  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Bristol-Myers Squibb Company
  • Janssen Pharmaceuticals, Inc.
  • Merck Sharp & Dohme Corp.
  • Hoffmann-La Roche Ltd
  • Vertex Pharmaceuticals Incorporated

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/hepatitis-c-drug-market-101562

Hepatitis C is a viral infection that causes severe damage such as inflammation of the liver and can spread through contaminated blood. The advanced stages of hepatitis C can also lead to liver damage, thereby creating severe health risks. The severity of hepatitis C has created a huge emphasis on the research and development of drugs associated with the treatment of this disease. Several new drugs have been launched in recent times, due to the high prevalence of hepatitis C across the world. Hepatitis C requires oral injections and dosages on a weekly basis, and it also has several side effects that can also lead to permanent damage.

Increasing clinical trials and successful drug clearances have aided the overall growth of the global hepatitis C market. Increasing number of regulatory approvals will boost the global hepatitis C market in the forthcoming years.

Segmentation:

By Product Type

  • NS5A Inhibitor (Protease Inhibitors)
  • Fixed-dose Combination

By Disease Type

  • Acute Hepatitis C
  • Chronic Hepatitis C

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

More Trending Topics From Fortune Business [email protected]

Surgical Stapling Devices Market 2019 Worldwide Share, Business Advancements, Industry Analysis, Trends, Forecast 2026

Orphan Drugs Market 2019: Industry Trends, Size, Growth Insight, Share, Competitive Analysis, Statistics, Regional, And Global Industry Forecast up to 2025

Transrectal Ultrasound Market 2019: Report Explored in Latest Research, Analysis Of Industry Forecast– 2026

Breast Cancer Therapeutics Market 2019 Global Size, Trends, Revenue, Share, Demands Research Report, Forecast till 2026

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close